tiprankstipranks
Trending News
More News >
Zevra Therapeutics (ZVRA)
NASDAQ:ZVRA

Compare Zevra Therapeutics (ZVRA) vs. Competitors

Compare
1,032 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Zevra Therapeutics
$8.93
$502.74M
14.16
12.61%
6 Buy
0 Hold
0 Sell
Strong Buy
Lexicon Pharmaceuticals
$1.37
$497.86M
-7.23
92.15%
3 Buy
0 Hold
0 Sell
Strong Buy
Prothena
$9.35
$503.31M
-1.79
-29.06%
4 Buy
1 Hold
1 Sell
Moderate Buy
Ocugen
$1.69
$527.82M
-7.80
136.36%
3 Buy
0 Hold
0 Sell
Strong Buy
Corvus Pharmaceuticals
$8.05
$601.19M
-15.05
70.19%
3 Buy
0 Hold
0 Sell
Strong Buy
Solid Biosciences
$5.47
$426.17M
-2.19
68.31%
11 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ZVRA
Zevra Therapeutics
8.93
0.78
9.57%
LXRX
Lexicon Pharmaceuticals
1.37
0.58
73.42%
PRTA
Prothena
9.35
-4.76
-33.73%
OCGN
Ocugen
1.69
0.94
125.33%
CRVS
Corvus Pharmaceuticals
8.05
2.83
54.21%
SLDB
Solid Biosciences
5.47
2.21
67.79%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts